NCT04564716View on ClinicalTrials.gov

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus

PHASE3UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

March 28, 2021

Study Completion Date

April 10, 2021

Conditions
Covid19
Interventions
BIOLOGICAL

Gam-COVID-Vac

vaccine for intramuscular injection

OTHER

Placebo

placebo comparator

Trial Locations (8)

Unknown

"Health Institution 14th Central Regional Polyclinic of the Partisan district of Minsk", Minsk

"Health Institution 19th Central Regional Polyclinic of the Pervomaysk district of Minsk", Minsk

"Health Institution 1st Central Regional Clinical Polyclinic of the Central district of Minsk", Minsk

"Health Institution 28th Regional Polyclinic of Minsk", Minsk

"Health Institution 4th City Polyclinic of Minsk", Minsk

"Health Institution 5th City Clinical Polyclinic of Minsk", Minsk

"Health Institution Minsk Order of the Red Banner of Labor Regional Clinical Hospital", Minsk

"Health Institution Vitebsk Regional Clinical Hospital", Vitebsk

Sponsors

Collaborators (1)

CRO: iPharma
All Listed Sponsors
collaborator

Russian Direct Investment Fund

INDUSTRY

collaborator

CRO: iPharma

UNKNOWN

lead

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

OTHER